Kardigan, Inc. (KARD)
14.87
+0.08
(+0.54%)
USD |
NASDAQ |
Oct 05, 12:50
Kardigan EPS Diluted (Quarterly) : -1.244 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.244 |
| March 31, 2026 | -0.6276 |
| Date | Value |
|---|---|
| June 30, 2025 | -0.643 |
| March 31, 2025 | -0.2017 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.268 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Eli Lilly & Co. | 7.939 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -116.24M |
| Total Expenses (Quarterly) | 116.24M |
| Enterprise Value | 798.14M |
| Earnings Yield | -18.26% |
| Normalized Earnings Yield | -15.87 |